Document Detail

Circadian variations of platelet aggregability and fibrinolytic activity in patients with ischemic stroke.
MedLine Citation:
PMID:  1788833     Owner:  NLM     Status:  MEDLINE    
The purpose of this study was to determine circadian dynamics of platelet aggregability and fibrinolytic activity in patients with ischemic stroke. The study was carried out in 21 male patients, aged from 51 to 65 years in acute phase of severe hemispheric brain infarction diagnosed clinically and radiologically. The examinations showed that circadian variations of platelet aggregability and fibrinolytic activity were persistent, but the intervals and the degree of oscillation differed from those in healthy persons. The significance of these disorders for clinical purposes was discussed.
A Jovicić; V Ivanisević; R Nikolajević
Related Documents :
22402243 - Pomolic acid, triterpenoid isolated from licania pittieri, as competitive antagonist of...
14624053 - Leukocyte cd15 expression and platelet activation in the coronary sinus after coronary ...
17636193 - Preliminary study showing the relationship between platelet fibronectin, sialic acid, a...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Thrombosis research     Volume:  64     ISSN:  0049-3848     ISO Abbreviation:  Thromb. Res.     Publication Date:  1991 Nov 
Date Detail:
Created Date:  1992-03-20     Completed Date:  1992-03-20     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0326377     Medline TA:  Thromb Res     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  487-91     Citation Subset:  IM    
Clinic of Neurology, Military Medical Academy, Belgrade, Yugoslavia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Coagulation Tests
Brain Ischemia / blood*
Cerebral Infarction / blood*
Circadian Rhythm*
Middle Aged
Platelet Aggregation*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Studies on fibrin network structure in human plasma. Part II--Clinical application: diabetes and ant...
Next Document:  Gemfibrozil predictably lowers triglycerides but does not significantly change plasminogen activator...